Human papillomavirus in the oral cavity of patients with and without renal transplantation

Transplantation

Volumn 82, Issue 4, 2006, Pages 570-573

  Rose, Barbara ^a,b,d   Wilkins, Douglas ^b   Li, Wei ^a,b   Tran, Nham ^a,b   Thompson, Carol ^b   Cossart, Yvonne ^b   McGeechan, Kevin ^c   O'Brien, Christopher ^a   Eris, Josette ^a  

^a ROYAL PRINCE ALFRED HOSPITAL   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

^c UNIVERSITY OF SYDNEY   (Australia)

^d CANCER INSTITUTE NSW   (Australia)

Author keywords

Cancer; Human papillomavirus; Immunosuppression; Oral cavity; Renal transplant

Indexed keywords

ANTIVIRUS AGENT; AZATHIOPRINE; CYCLOSPORIN; IMMUNOSUPPRESSIVE AGENT; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; RAPAMYCIN; VIRUS DNA;

ADULT; ALCOHOL CONSUMPTION; ARTICLE; CONTROLLED STUDY; DNA DETERMINATION; FEMALE; GRAFT RECIPIENT; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 16; IMMUNOSUPPRESSIVE TREATMENT; INFECTION RISK; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MOUTH CAVITY; POLYMERASE CHAIN REACTION; POSTOPERATIVE INFECTION; PRIORITY JOURNAL; SEXUALITY; VIRUS INFECTION; WART VIRUS;

ADULT; AGED; AGED, 80 AND OVER; DNA, VIRAL; FEMALE; HUMANS; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; MOUTH; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; RISK FACTORS;

EID: 33747893716     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.tp.0000231706.79165.e5     Document Type: Article

References (20)

1. Herrero R, Castellsague X, Pawlita M, et al. Human papillomavirus and oral cancer: the International Agency for Research on Cancer multicenter study. J Natl Cancer Inst 2003; 95(23): 1772.
2. Peto J. Cancer epidemiology in the last century and the next decade. Nature 2001; 411(6835): 390.
3. Johnson JC, Burnett AF, Willet GD, et al. High frequency of latent and clinical human papillomavirus cervical infections in immunocompromised human immunodeficiency virus-infected women. Obstet Gynecol 1992; 79(3): 321.
4. Harwood CA, Spink PJ, Surentheran T, et al. Degenerate and nested PCR: a highly sensitive and specific method for detection of human papillomavirus infection in cutaneous warts. J Clin Microbiol 1999; 37(11): 3545.
5. Resnick RM, Cornelissen MT, Wright DK, et al. Detection and typing of human papillomavirus in archival cervical cancer specimens by DNA amplification with consensus primers. J Natl Cancer Inst 1990; 82(18): 1477.
6. Manos MM, Waldman J, Zhang TY, et al. Epidemiology and partial nucleotide sequence of four novel genital human papillomaviruses. J Infect Dis 1994 Nov.; 170(5): 1096-9.
7. Forslund O, Antonsson A, Nordin P, et al. A broad range of human papillomavirus types detected with a general PCR method suitable for analysis of cutaneous tumours and normal skin. J Gen Virol 1999; 80(Pt 9): 2437.
8. Rose BR, Thompson CH, Chantrill LA, et al. Prevalence and distribution of human papillomavirus type-16 DNA in pelvic lymph nodes of patients with cervical cancer and in women with no history of cervical abnormality. Int J Cancer 1992; 52(2): 225.
9. McNutt LA, Wu C, Xue X, Hafner JP. Estimating the relative risk in cohort studies and clinical trials of common outcomes. Am J Epidemiol 2003; 157(10): 940.
10. Tideman RL, Thompson C, Rose B, et al. Cervical human papillomavirus infections in commercial sex workers-risk factors and behaviours. Int J STD AIDS 2003; 14(12): 840.
11. Leigh IM, Buchanan JA, Harwood CA, et al. Role of human papillomaviruses in cutaneous and oral manifestations of immunosuppression. J Acquir Immune Defic Syndr 1999; 21 (Suppl 1): S49.
12. Schiffman M, Kjaer SK. Chapter 2: Natural history of anogenital human papillomavirus infection and neoplasia. J Natl Cancer Inst Monogr 2003(31): 14.
13. Abramson AL, Nouri M, Mullooly V, et al. Latent Human Papillomavirus infection is comparable in the larynx and trachea. J Med Virol 2004; 72(3): 473.
14. Smith EM, Ritchie JM, Summersgill KF, et al. Human papillomavirus in oral exfoliated cells and risk of head and neck cancer. J Natl Cancer Inst 2004; 96(6): 449.
15. Kurose K, Terai M, Soedarsono N, et al. Low prevalence of HPV infection and its natural history in normal oral mucosa among volunteers on Miyako Island, Japan. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2004; 98(1): 91.
16. Terai M, Hashimoto K, Yoda K, Sata T. High prevalence of human papillomaviruses in the normal oral cavity of adults. Oral Microbiol Immunol 1999; 14(4): 201.
17. Summersgill KF, Smith EM, Levy BT, et al. Human papillomavirus in the oral cavities of children and adolescents. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2001; 91(1): 62.
18. Ammatuna P, Campisi G, Giovannelli L, et al. Presence of Epstein-Barr virus, cytomegalovirus and human papillomavirus in normal oral mucosa of HIV-infected and renal transplant patients. Oral Dis 2001; 7(1): 34.
19. Gillison ML, Koch WM, Capone RB, et al. Evidence for a causal association between human papillomavirus and a subset of head and neck cancers. J Natl Cancer Inst 2000; 92(9): 709.
20. Smith EM, Ritchie JM, Summersgill KF, et al. Age, sexual behavior and human papillomavirus infection in oral cavity and oropharyngeal cancers. Int J Cancer 2004; 108(5): 766.